Publications by authors named "Valentin Goede"

Claim this Profile
A
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial.
Florian Simon, Rudy Ligtvoet, Jan-Paul Bohn, Thomas Nösslinger, Julia von Tresckow, Valentin Goede

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia.
Valentin Goede, Kirsten Fischer, Sandra Robrecht, Adam Giza, Martin J S Dyer

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of lung cancer in older adults.
Sven Stieglitz, Valentin Goede, Andreas Schlesinger

Z Gerontol Geriatr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.
Florian Simon, Rudy Ligtvoet, Sandra Robrecht, Paula Cramer, Nadine Kutsch, Valentin Goede

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Frailty in Oncology: Updated Recommendations for Clinical Practice].
Valentin Goede, Ulrich Wedding

Dtsch Med Wochenschr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies.
Petra Langerbeins, Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Valentin Goede

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty is also a target for targeted drugs in CLL.
Valentin Goede

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty and Cancer: Current Perspectives on Assessment and Monitoring.
Valentin Goede

Clin Interv Aging· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL.
Paul J Hengeveld, Michèle Y van der Klift, P Martijn Kolijn, Frédéric Davi, François G Kavelaars, Valentin Goede

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older.
Florian Simon, Adam Giza, Sandra Robrecht, Anna-Maria Fink, Paula Cramer, Valentin Goede

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive approach to therapy of haematological malignancies in older patients.
Raul Cordoba, Toby A Eyre, Heidi D Klepin, Tanya M Wildes, Valentin Goede

Lancet Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty assessment in the care of older people with haematological malignancies.
Valentin Goede, Nina Rosa Neuendorff, Ralf-Joachim Schulz, Ana-Isabel Hormigo, Francisco Javier Martinez-Peromingo

Lancet Healthy Longev· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Malignant Diseases in the Elderly].
Valentin Goede, Michael von Bergwelt-Baildon

Dtsch Med Wochenschr· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
Sonia Jaramillo, Andreas Agathangelidis, Christof Schneider, Jasmin Bahlo, Sandra Robrecht, Valentin Goede

Haematologica· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription.
Jennifer Edelmann, Karlheinz Holzmann, Eugen Tausch, Emily A Saunderson, Billy M C Jebaraj, Valentin Goede

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Multiple myeloma in old people : Practical skills for geriatricians and general practitioners].
Valentin Goede

Z Gerontol Geriatr· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age.
Monika Engelhardt, Gabriele Ihorst, Jesus Duque-Afonso, Ulrich Wedding, Ernst Spät-Schwalbe, Valentin Goede

Haematologica· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy.
Moritz Fürstenau, Georg Hopfinger, Sandra Robrecht, Anna-Maria Fink, Othman Al-Sawaf, Valentin Goede

Leukemia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
Othman Al-Sawaf, Alexandra Bazeos, Sandra Robrecht, Jasmin Bahlo, Craig Gower, Valentin Goede

Am J Hematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, Wolfgang Hiddemann, Robert Marcus, Valentin Goede

Clin Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
Kirsten Fischer, Othman Al-Sawaf, Jasmin Bahlo, Anna-Maria Fink, Maneesh Tandon, Valentin Goede

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary care in the hematology clinic: Implementation of geriatric oncology.
Valentin Goede, Reinhard Stauder

J Geriatr Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.
Anton W Langerak, Matthias Ritgen, Valentin Goede, Sandra Robrecht, Jasmin Bahlo

Blood· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
Othman Al-Sawaf, Jasmin Bahlo, Sandra Robrecht, Kirsten Fischer, Carmen D Herling, Valentin Goede

Br J Haematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of unfit elderly patients with chronic lymphocytic leukemia.
Barbara Eichhorst, Michael Hallek, Valentin Goede

Eur J Intern Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis